demonstrated that IL-6-induced activation of the JAK2/BECN1 pathway ultimately regulates PI3KC3 complex formation, and that this complex is a predictive marker for poor CRC prognosis and chemotherapeutic response (158). Here, IL6 is linked to colorectal carcinoma.